Meclofenoxate hydrochlorideDrug for senile dementia and AD treatment CAS# 3685-84-5 |
2D Structure
- Licofelone
Catalog No.:BCC4432
CAS No.:156897-06-2
- Lumiracoxib
Catalog No.:BCC4440
CAS No.:220991-20-8
- Bufexamac
Catalog No.:BCC4427
CAS No.:2438-72-4
- Triflusal
Catalog No.:BCC4443
CAS No.:322-79-2
- Nabumetone
Catalog No.:BCC4434
CAS No.:42924-53-8
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 3685-84-5 | SDF | Download SDF |
PubChem ID | 19379 | Appearance | Powder |
Formula | C12H17Cl2NO3 | M.Wt | 294.17 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : ≥ 50 mg/mL (169.97 mM) H2O : 33.33 mg/mL (113.30 mM; Need ultrasonic) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate;hydrochloride | ||
SMILES | CN(C)CCOC(=O)COC1=CC=C(C=C1)Cl.Cl | ||
Standard InChIKey | FIVHOHCAXWQPGC-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C12H16ClNO3.ClH/c1-14(2)7-8-16-12(15)9-17-11-5-3-10(13)4-6-11;/h3-6H,7-9H2,1-2H3;1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Meclofenoxate hydrochloride, an ester of dimethylethanolamine (DMAE) and 4-chlorophenoxyacetic acid (pCPA), has been shown to improve memory, have a mentally stimulating effect, and improve general cognition.
IC50 value:
Target: nootropic
Meclofenoxate, administered in a dose of 50 mg/kg twice daily for 7 days using the maze-training method, increased the number of responses to the conditioned stimulus, when retention tests were made 24 hours and 7 days after training, whereas citicholine, applied in the same way in a dose of 10 mg/kg, shortened the latency of the responses with reinforcement during the training and increased the number of correct responses to the conditioned stimulus in retention tests 7 days after the training [1]. Meclofenoxate appears to increase the consolidation of new information into long-term memory, but does not affect other aspects of remembering [2]. References: |
Meclofenoxate hydrochloride Dilution Calculator
Meclofenoxate hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.3994 mL | 16.997 mL | 33.9939 mL | 67.9879 mL | 84.9849 mL |
5 mM | 0.6799 mL | 3.3994 mL | 6.7988 mL | 13.5976 mL | 16.997 mL |
10 mM | 0.3399 mL | 1.6997 mL | 3.3994 mL | 6.7988 mL | 8.4985 mL |
50 mM | 0.068 mL | 0.3399 mL | 0.6799 mL | 1.3598 mL | 1.6997 mL |
100 mM | 0.034 mL | 0.17 mL | 0.3399 mL | 0.6799 mL | 0.8498 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Meclofenoxate hydrochloride, an ester of dimethylethanolamine (DMAE) and 4-chlorophenoxyacetic acid (pCPA), has been shown to improve memory, have a mentally stimulating effect, and improve general cognition.
- 1,5-Pentanediol diacrylate
Catalog No.:BCC8426
CAS No.:36840-85-4
- Naringenin triacetate
Catalog No.:BCN5425
CAS No.:3682-04-0
- Isohemiphloin
Catalog No.:BCN5424
CAS No.:3682-02-8
- Puerarin
Catalog No.:BCN5958
CAS No.:3681-99-0
- Vitexin
Catalog No.:BCN5423
CAS No.:3681-93-4
- Ribavirin
Catalog No.:BCC4935
CAS No.:36791-04-5
- MRS 2279
Catalog No.:BCC5880
CAS No.:367909-40-8
- 4-Aminophthalimide
Catalog No.:BCC8689
CAS No.:3676-85-5
- 10-Shogaol
Catalog No.:BCN3267
CAS No.:36752-54-2
- AR-M 1896
Catalog No.:BCC5931
CAS No.:367518-31-8
- Lurasidone HCl
Catalog No.:BCC4458
CAS No.:367514-88-3
- Lurasidone
Catalog No.:BCC9013
CAS No.:367514-87-2
- Tramiprosate
Catalog No.:BCC7727
CAS No.:3687-18-1
- Aucuparin
Catalog No.:BCN7450
CAS No.:3687-28-3
- TC 14012
Catalog No.:BCC7910
CAS No.:368874-34-4
- p-Coumaryl alcohol
Catalog No.:BCN3922
CAS No.:3690-05-9
- Zebularine
Catalog No.:BCC1136
CAS No.:3690-10-6
- 6-epi-Augustifolin
Catalog No.:BCN3233
CAS No.:369390-94-3
- Hydramicromelin B
Catalog No.:BCN7560
CAS No.:369391-55-9
- Icilin
Catalog No.:BCC4074
CAS No.:36945-98-9
- Oroxylin A 7-O-beta-D-glucuronide
Catalog No.:BCN2337
CAS No.:36948-76-2
- TMPyP4 tosylate
Catalog No.:BCC7899
CAS No.:36951-72-1
- FCCP
Catalog No.:BCC5659
CAS No.:370-86-5
- Zinterol hydrochloride
Catalog No.:BCC6911
CAS No.:37000-20-7
Kinetics of hydrolysis of meclofenoxate hydrochloride in human plasma.[Pubmed:2883287]
J Pharm Pharmacol. 1987 Mar;39(3):215-8.
The kinetics of hydrolysis of Meclofenoxate hydrochloride in human plasma have been compared with those of clofibrate. The hydrolysis rate in fractionated plasma was determined in the presence and absence of a plasma esterase inhibitor, tetraethyl pyrophosphate. The kinetic data indicated that clofibrate decomposed only by esterase-induced hydrolysis, which was inhibited by binding of clofibrate to plasma proteins. In contrast to clofibrate, meclofenoxate decomposed rapidly in human plasma via spontaneous hydrolysis as well as esterase-induced hydrolysis. The spontaneous hydrolysis appeared to be inhibited by some components present in the esterase fraction isolated from plasma, while no significant inhibition of the hydrolysis by protein binding was observed.
Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy Chinese adult male volunteers: a randomized sequence, open-label, two-period crossover study.[Pubmed:18840370]
Clin Ther. 2008 Sep;30(9):1651-7.
BACKGROUND: Meclofenoxate hydrochloride is a psychostimulant in the nootropic agent group available in capsule and tablet formulations approved for traumatic cataphora, alcoholic poisoning, anoxia neonatorum, and children's enuresis in China. Although these 2 generic formulations are marketed in China, information regarding their pharmacokinetics and bioequivalence in humans has not been published. OBJECTIVE: The aim of this study was to compare the pharmacokinetic properties and bioequivalence of the capsule (test) and tablet (reference) formulations of Meclofenoxate hydrochloride 200 mg in healthy Chinese volunteers. METHODS: This single-dose, randomized-sequence, open-label, 2-period crossover study was performed at the Nanjing First Hospital of Nanjing Medical University, Nanjing, China. Eligible subjects were healthy male volunteers who were randomly assigned at a 1:1 ratio to receive a single 200-mg dose of the test or reference formulation, followed by a 1-week washout period and administration of the alternate formulation. The study drugs were administered after a 12-hour overnight fast. As a prodrug, meclofenoxate is hydrolyzed into 4-chlorophenoxyacetic acid and is not detected in plasma. The active metabolite of meclofenoxate, chlorophenoxyacetic acid, was assayed using a high-performance liquid chromatography method. For analysis of pharmacokinetic properties, including Cmax, AUC0-24, and AUC0-infinity, blood samples were obtained at 0.33, 0.67, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 14, and 24 hours after administration. The formulations were considered bioequivalent if the log-transformed ratios of Cmax and AUC were within the predetermined equivalence range (80%-125%) as established by the US Food and Drug Administration (FDA). Subjects were interviewed concerning the occurrence of adverse events including excitement, insomnia, lassitude, and headache. Tolerability was assessed at baseline (before administration) and at 1, 2, 6, and 12 hours after administration by monitoring vital signs and laboratory tests (hematology, blood biochemistry, hepatic function, and urinalysis). RESULTS: Twenty-four Chinese male subjects (mean [range]age,23.5[22-30]years;weight,63.3[56-68]kg; height, 171 [165-184] cm) were enrolled; all completed the study. No period or sequence effect was observed. The 90% CIs for the log-transformed ratios of chlorophenoxyacetic acid Cmax, AUC0-24, and AUC0-infinity were 95.7 to 122.9, 97.6 to 111.9, and 97.8 to 111.7, respectively (all, P>0.05). Similar results were found for the data without log-transformation. No adverse events were reported or observed during this single-dose study. CONCLUSIONS: In this small study in healthy Chinese adult male volunteers, a single 200-mg dose of the capsule formulation was found to be bioequivalent to a single 200-mg dose of the tablet formulation based on the US FDA's regulatory definition (rate and extent of absorption). Both formulations were well tolerated.
Construction and performance characteristics of new ion selective electrodes based on carbon nanotubes for determination of meclofenoxate hydrochloride.[Pubmed:22632051]
Anal Chim Acta. 2012 Jun 12;730:99-111.
This work offers construction and comparative evaluation the performance characteristics of conventional polymer (I), carbon paste (II) and carbon nanotubes chemically modified carbon paste ion selective electrodes (III) for Meclofenoxate hydrochloride are described. These electrodes depend mainly on the incorporation of the ion pair of Meclofenoxate hydrochloride with phosphomolybdic acid (PMA) or phosphotungestic acid (PTA). They showed near Nernestian responses over usable concentration range 1.0 x 10(-5) to 1.0 x 10(-2)M with slopes in the range 55.15-59.74 mV(concentrationdecade)(-1). These developed electrodes were fully characterized in terms of their composition, response time, working concentration range, life span, usable pH and temperature range. The electrodes showed a very good selectivity for Meclo with respect to a large number of inorganic cations, sugars and in the presence of the degradation product of the drug (p-chloro phenoxy acetic acid). The standard additions method was applied to the determination of MecloCl in pure solution, pharmaceutical preparations and biological samples. Dissolution testing was also applied using the proposed sensors.